// App-Quantinova.ai

: Association of very small nuclear circulating tumor cell (vsnCTC) with clinical outcomes in metastatic castration-resistant prostate cancer.

Researchers

Presenter

  • Jasmine Jiemei Wang

Principal Investigators

  • Yu Jen Jan

  • Jie-Fu Chen

  • Galen Cook-Wiens

  • Nu Yao

  • Gina Chia-Yi Chu

  • Pin-Jung Chen

  • Hao Ho

  • Yingying Yang

  • Yi-Te Lee

  • Jiaoti Huang

  • Leland WK Chung

  • Sungyong You

  • Yazhen Zhu

  • Michael Freeman

  • Andre Rogatko

  • Ju Dong Yang

  • Hsian-Rong Tseng

  • Edwin M. Posadas

Medical Centers

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai, Los Angeles, CA

  • California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA

  • Institute of Statistical Sciences, Academia Sinica, Taipei, Taiwan

  • University of California, Los Angeles, Los Angeles, CA

  • Duke University College of Medicine, Durham, NC

  • Cedars-Sinai Medical Center, Hollywood, CA

Locations

  • United States

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

Drug/Treatment

  • Enzalutamide

  • CB-7598

  • Androgen Tear

  • taxane

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved